Captrust Financial Advisors Vericel Corp Transaction History
Captrust Financial Advisors
- $43.1 Billion
- Q2 2025
A detailed history of Captrust Financial Advisors transactions in Vericel Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 6,849 shares of VCEL stock, worth $237,249. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,849
Previous 4,907
39.58%
Holding current value
$237,249
Previous $218,000
33.49%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding VCEL
# of Institutions
294Shares Held
54MCall Options Held
35.6KPut Options Held
7.7K-
Black Rock Inc. New York, NY8.06MShares$279 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$123 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD2.81MShares$97.4 Million3.59% of portfolio
-
Conestoga Capital Advisors, LLC2.46MShares$85.3 Million1.56% of portfolio
-
State Street Corp Boston, MA2.44MShares$84.4 Million0.0% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.63B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...